Cryopreserved Platelets (CPP) for US FDA Licensure

Description

{"description":" Defense Health Agency seeks to develop and manage medical materiel to protect and sustain the Warfighter on point for the Nation. We develop, directly through collaboration with commercial partners, medical products that enhance readiness and improve the quality of life of active-duty personnel in the operational environment. OPMED’s WPAC PMO has been developing a biologic product: Dimethyl Sulfoxide (DMSO) Cryopreserved Platelets (CPP), a frozen, biologic-platelet product. DMSO CPP are formulated to provide a platelet-derived product with a longer shelf life (2 years and potentially longer) than liquid stored platelets (LSP), which are currently licensed for storage up to 5-7 days at room temperature (20ºC to 24ºC) under gentle agitation. \n"} Solicitation Number: HT9427-26-RFI-705 Type: Sources Sought Base Type: Sources Sought NAICS: 541715 Response Deadline: 2026-05-04T15:00:00-04:00 Office Address: FORT DETRICK, MD Place of Performance: Frederick, Maryland, 21702 POC: Peter Mitchell, peter.d.mitchell8.civ@health.mil POC: Kelly Green, kelly.r.green.civ@health.mil